Literature DB >> 132977

Comparison of the actions of acebutolol, practolol and propranolol on calcium transport by heart microsomes and mitochondria.

N S Dhalla, S L Lee.   

Abstract

1 The effects of acebutolol, practolol and propranolol (0,5-3 mM) on calcium uptake, calcium binding and ATPase activities of the rabbit and rat heart microsomal and mitochondrial fractions were investigated. 2 Dose-response and time course experiments revealed that propranolol greatly inhibited microsomal and mitochondrial calcium uptake whereas both acebutolol and practolol showed slight depressant effects. 3 The ATPase activities of microsomal and mitochondrial fractions were decreased by acebutolol, practolol and propranolol; however, the latter agent was more effective than the other two. 4 The inhibitory effects of acebutolol, practolol and propranolol on mitochondria and microsomes were not antagonized by adrenaline. 5 Propranolol decreased calcium binding by the microsomal fraction only, whereas acebutolol and practolol had no effect on microsomal or mitochondrial calcium binding. 6 The sensitivity of the rabbit heart subcellular fractions to the beta-adrenoceptor blocking drugs was similar to that of the rat heart; however, the calcium uptake and ATPase activities of microsomes were more sensitive to propranolol than mitochondria in both species. 7 Perfusion of rat hearts with 0.2-1 mM propranolol decreased contractile force, and microsomal and mitochondrial fractions obtained from these hearts accummulated less calcium in comparison to the control. On the other hand, acebutolol and practolol (0.2-1nM) had no appreciable effects on contractile force or subcellular fractions under similar conditions. 8 The negative inotropic effect of propranolol may partly be due to its inhibitory actions on calcium transport by subcellular organelles of the myocardium; the depressant action of propranolol on calcium transport is unlikely to be due to its beta-adrenoceptor blocking property.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132977      PMCID: PMC1667120          DOI: 10.1111/j.1476-5381.1976.tb07470.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  A microcolorimetric method for the determination of inorganic phosphorus.

Authors:  H H TAUSSKY; E SHORR
Journal:  J Biol Chem       Date:  1953-06       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The influence of some cardioactive drugs on the energy-dependent uptake of calcium, potassium and adenine nucleotides by mitchondria.

Authors:  E Noack; K Greeff
Journal:  J Mol Cell Cardiol       Date:  1971-06       Impact factor: 5.000

4.  Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.

Authors:  A J Coleman; W P Leary
Journal:  Curr Ther Res Clin Exp       Date:  1972-10

5.  The effect of pronethalol and propranolol on lipid-facilitated transport of calcium ions.

Authors:  W G Nayler
Journal:  J Pharmacol Exp Ther       Date:  1966-09       Impact factor: 4.030

6.  Effects of propranolol and its optical isomers on the radiocalcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF).

Authors:  B Scales; D A McIntosh
Journal:  J Pharmacol Exp Ther       Date:  1968-04       Impact factor: 4.030

7.  Mechanism of propranolol inhibition of the cardiac sarcotubule-gamma-AT32P reaction.

Authors:  D C Pang; F N Briggs
Journal:  Biochem Pharmacol       Date:  1973-06-01       Impact factor: 5.858

Review 8.  Molecular abnormalities in cardiomyopathy.

Authors:  N S Dhalla; P V Sulakhe; M Fedelesova; J C Yates
Journal:  Adv Cardiol       Date:  1974

9.  Excitation-contraction coupling in heart. VII. Calcium accumulation in subcellular particles in congestive heart failure.

Authors:  P V Sulakhe; N S Dhalia
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.

Authors:  B Basil; R Jordan; A H Loveless; D R Maxwell
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

View more
  8 in total

1.  Interaction of some antiarrhythmic drugs with the heart sarcolemmal Na+-Ca2+ exchange system.

Authors:  D A Eyolfson; N S Dhalla
Journal:  Basic Res Cardiol       Date:  1989 Jul-Aug       Impact factor: 17.165

2.  Stimulant and depressant effects of beta-adrenoceptor blocking agents on isolated heart muscle. A positive inotropic effect not mediated through andrenoceptors.

Authors:  A J Kaumann; J R Blinks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

3.  Normothermic ischemic cardiac arrest in the isolated working rabbit heart: effects of dl-nebivolol and atenolol.

Authors:  G Vandeplassche; H R Lu; L Wouters; W Flameng; M Borgers
Journal:  Basic Res Cardiol       Date:  1991 Jan-Feb       Impact factor: 17.165

Review 4.  The management of acute poisoning due to beta-adrenoceptor antagonists.

Authors:  J A Critchley; A Ungar
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

5.  Effects of (+)-propranolol on intracellular mechanisms of contraction in striated muscle of the rabbit.

Authors:  J Y Su; D A Malencik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Alterations in the heart sarcolemmal Ca2+ transport activity by some beta-adrenergic antagonists.

Authors:  A Dzurba; P K Ganguly; A Guerin; N S Dhalla
Journal:  Basic Res Cardiol       Date:  1984 Nov-Dec       Impact factor: 17.165

7.  Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog.

Authors:  W Chernecki; P K Das; N S Dhalla; G P Sharma
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

Review 8.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.